How will the convergence of AI with quantum computing, bioengineering, advanced materials, and robotics accelerate transformation across sectors? This session examines how breakthroughs at these intersections can unlock new capabilities—from intelligent therapeutics to autonomous industrial systems. Speakers explore implementation pathways, enabling policy frameworks, and how organizations can harness convergence responsibly for both competitive advantage and societal benefit. This session was developed in partnership with Imperial College London.

Speakers

• Hugh Brady, President, Imperial College London

• Amanda Wolthuizen, Vice President, Imperial College London

• Jason Kelly, CEO, Ginkgo Bioworks

• Matt James, Chief Animal Officer, Colossal Biosciences